Delivery Order SPE2DB20D2104-SPE2DB24FMCBC

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMLNH, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,310.28 Firm Fixed Price Delivery Order covers the supply of 4567645297 ! CYANOCOBALAMIN 500 MCG SPRAYS, with a completion date of March 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Cyanocobalamin 500 mcg sprays to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 30, 2025, with a ceiling value of $2,953.58 and an ultimate completion date of January 31, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation....
This federal contract award is for the delivery of 4566691829 - Cyanocobalamin 500 MCG Sprays. The $3,962.16 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of December 12, 2024 and is a firm fixed price delivery order. There is no set-aside designation noted. Amerisourcebergen Drug Corp is the prime contractor and holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of CYANOCOBALAMIN 500 MCG SPRAYS to the Defense Logistics Agency (DLA), a defense agency. The firm fixed-price contract, valued at $24,541.84, was awarded on June 9, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 10, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYANOCOBALAMIN 500 MCG SPRAYS, with a ceiling value of $7,195.49 and a period of performance through May 29, 2025. The contract is not set aside and was awarded on May 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $3,810.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567632044 ! CYANOCOBALAMIN 500 MCG SPRAYS, a vitamin B12 supplement. The contract is a Firm Fixed Price Delivery Order that runs through March 20, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CYANOCOBALAMIN 500 MCG SPRAYS. The contract has a ceiling value of $1,257.64 and is a firm fixed-price contract, with a performance period ending on July 11, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of CYANOKIT 5 gram vials, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,964.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of March 14, 2025 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,591.90 firm fixed-price delivery order contract has a completion date of March 4, 2025 and does not utilize any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,685.01 firm fixed-price delivery order contract has an ultimate completion date of March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMCBC
    Delivery Order

This federal contract award, with ID SPE2DB20D2104|SPE2DB24FMCBC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,331.20 firm fixed-price delivery order is for the supply of 4565891635 - Cyanocobalamin 500 MCG Sprays. The contract has an ultimate completion date of September 23, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is not designated with any set-aside requirements, indicating open competition. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:33 AM